Repeated suprascapular nerve block in hemiplegic shoulder pain in reducing shoulder pain and improving range of motion

Repeated suprascapular nerve block in hemiplegic shoulder pain in reducing shoulder pain and improving range of motion: a randomized controlled trial - Nil

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/02/080055

Enrollment

Registered

2025-02-07

Start date

Unknown

Completion date

Unknown

Last updated

2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M958- Other specified acquired deformities of musculoskeletal system

Interventions

Intervention1: Suprascapular nerve block (with xylocaine): Repeated suprascapular nerve block with 2 ml of Inj. Lignocaine (1%). Nerve block will be performed 15mins before the rehabilitation program,

Eligibility

Inclusion criteria

Inclusion criteria: Age: 18-80 years MRI confirmed stroke within the previous 12 months with hemiplegic shoulder pain Patients willing to provide informed consent

Exclusion criteria

Exclusion criteria: Patient who have history of shoulder pain on the same side before stroke Who have taken any form of interventional treatment for the shoulder pain Patient with uncontrolled diabetes, ischemic heart disease, cardiac arrhythmia or a pacemaker, hepatitis

Design outcomes

Primary

Measure	Time frame
1.Range of Motion (ROM) of the shoulder joint 2.PainTimepoint: 30 minutes, 1 week, 2 weeks and 4 weeks after the 1st nerve block	—

Secondary

Measure	Time frame
NilTimepoint:	—

Countries

India

Contacts

Public ContactDr Longjam Darendrajit Singh

Shija Academy of Health Sciences

darendrajit4u@gmail.com9856255474

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026